Innovative Universal CAR-T Cell Therapy Shows High Remission Rates in Aggressive T-Cell Blood Cancers
A pioneering international clinical trial has revealed that a new type of immunotherapy, designed to target some of the most aggressive and hard-to-treat blood...
